PHILADELPHIA — The American Thyroid Association (ATA) recently presented the Van Meter Award, to Anne R. Cappola, MD, ScM, associate professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism in the Perelman School of Medicine at the University of Pennsylvania. Dr. Cappola is an internationally recognized clinical investigator whose research on the hormonal changes associated with aging is impacting how clinicians evaluate and treat thyroid dysfunction in older people.
The award was established in 1930 to recognize outstanding contributions by a young clinical scientist to research on the thyroid gland. Dr. Cappola accepted the honor during the award lecture on October 18 at the ATA’s 83rd Annual Meeting in San Juan, Puerto Rico.
Dr. Cappola is a graduate of Harvard College and the Perelman School of Medicine at the University of Pennsylvania. She was a resident in Medicine at the Brigham and Women’s Hospital and a fellow in Endocrinology at the Massachusetts General Hospital and at the Johns Hopkins Hospital. She has also completed a Master of Science in Clinical Epidemiology and a fellowship in the Epidemiology of Aging at the Johns Hopkins Bloomberg School of Public Health. Dr. Cappola directs an NIH-funded research program on the hormonal alterations that occur with aging and the clinical impact of these changes, including the clinical impact of subclinical thyroid dysfunction in older individuals. She is an Associate Editor for JAMA, and she serves on the ATA’s Annual Meeting Program Committee and Thyroid Hormone Replacement Task Force.
The Van Meter Award receives support from Mary Ann Liebert, Inc., publishers of the journal Thyroid. For more information, please visit the American Thyroid Association.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.